Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
PURPOSE: The diagnosis of behavioural variant frontotemporal dementia (bvFTD) is challenging during the predementia stage when symptoms are subtle and confounding. Morphological and functional neuroimaging can be particularly helpful during this stage but few data are available. METHODS: We retrospectively selected 25 patients with late-onset probable bvFTD. Brain structural MRI and FDG PET were performed during the predementia stage (mean MMSE score 27.1 ± 2.5) on average 2 years before. The findings with the two imaging modalities were compared (SPM8) with those in a group of 20 healthy subjects. The bvFTD patients were divided into two subgroups: those with predominant disinhibition (bvFTD+) and those with apathy (bvFTD-). RESULTS: Hypometabolism exceeded grey matter (GM) density reduction in terms of both extension and statistical significance in all comparisons. In the whole bvFTD group, hypometabolism involved the bilateral medial, inferior and superior lateral frontal cortex, anterior cingulate, left temporal and right parietal cortices and the caudate nuclei. GM density reduction was limited to the right frontal cortex and the left medial temporal lobe. In bvFTD+ patients hypometabolism was found in the bilateral medial and basal frontal cortex, while GM reduction involved the left anterior cingulate and left inferior frontal cortices, and the right insula. In bvFTD- patients, atrophy and mainly hypometabolism involved the lateral frontal cortex and the inferior parietal lobule. CONCLUSION: These findings suggest that hypometabolism is more extensive than, and thus probably precedes, atrophy in predementia late-onset bvFTD, underscoring different topographic involvement in disinhibited and apathetic presentations. If confirmed in a larger series, these results should prompt biomarker operationalization in bvFTD, especially for patient selection in therapeutic clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eickhoff, S. B., Laird, A. R., Grefkes, C., Wang, L. E., Zilles, K., & Fox, P. T. (2009) · Human Brain Mapping · doi:10.1002/hbm.20718 · Cited by 1,924 · cited 1×
“3 [28].”
Paulus, M. P., & Stein, M. B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.042 · Cited by 1,325 · cited 1×
“The insula is involved in decision-making processes by integrating information about the internal emotional/ arousal states and the risk or uncertainty associated with current decisions [44].”
BackgroundMosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726 · cited 1×
“It has been shown that both atrophy [9, 10] and hypometabolism/hypoperfusion [6, 11–17] are detectable early in anterior cortical regions in overt FTD, when they can support the diagnosis [18] and help differentiate bvFTD from psychiatric disorders in the elderly [19].”
BackgroundDevelopment of methodology for conducting clinical trials in frontotemporal lobar degeneration
Knopman, D. S., Kramer, J. H., Boeve, B. F., Caselli, R. J., Graff-Radford, N. R., Mendez, M. F., Miller, B. L., & Mercaldo, N. (2008) · Brain · doi:10.1093/brain/awn234 · Cited by 442
Ber, I. L., Guedj, E., Gabelle, A., Verpillat, P., Volteau, M., Thomas-Anterion, C., Decousus, M., Hannequin, D., Vera, P., Lacomblez, L., et al. (2006) · Brain · doi:10.1093/brain/awl288 · Cited by 179
Kipps, C. M., Davies, R. R., Mitchell, J., Kril, J. J., Halliday, G. M., & Hodges, J. R. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100973 · Cited by 172 · cited 1×
“The relatively low sensitivity of structural MRI has already been shown in a study in 51 bvFTD patients, about half of whom failed to show significant atrophy by visual analysis even 5 years on average after diagnosis [35].”
BackgroundFrontotemporal Lobar Degeneration: Epidemiology, Pathology, Diagnosis and Management
Seltman, R. E., & Matthews, B. R. (2012) · CNS Drugs · doi:10.2165/11640070-000000000-00000 · Cited by 132
Kerklaan, B. J., van Berckel, B. N. M., Herholz, K., Dols, A., van der Flier, W. M., Scheltens, P., & Pijnenburg, Y. A. L. (2014) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317514524811 · Cited by 46
Identifying bvFTD within the wide spectrum of late onset frontal lobe syndrome: a clinical approach
Krudop, W. A., Kerssens, C. J., Dols, A., Prins, N. D., Möller, C., Schouws, S., van der Flier, W. M., Scheltens, P., Sikkes, S., Stek, M. L., et al. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.04.002 · Cited by 33 · cited 3×
“It has been shown that both atrophy [9, 10] and hypometabolism/hypoperfusion [6, 11–17] are detectable early in anterior cortical regions in overt FTD, when they can support the diagnosis [18] and help differentiate bvFTD from psychiatric disorders in the elderly [19].”
BackgroundMethodResult
Cited by
Imaging and fluid biomarkers in frontotemporal dementia
Meeter, L. H., Kaat, L. D., Rohrer, J. D., & van Swieten, J. C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.75 · Cited by 210
Gossye, H., Van Broeckhoven, C., & Engelborghs, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00757 · Cited by 34
Neurodegenerative Disorders of Speech and Language: Non-language-dominant Diseases
García, A. M., DeLeon, J., & Tee, B. L. (2022) · Encyclopedia of Behavioral Neuroscience, 2nd edition · doi:10.1016/b978-0-12-819641-0.00042-6 · Cited by 10
Metadata
- Authors
- Morbelli, S., Ferrara, M., Fiz, F., Dessi, B., Arnaldi, D., Picco, A., Bossert, I., Buschiazzo, A., Accardo, J., Picori, L., Girtler, N., Mandich, P., Pagani, M., Sambuceti, G., & Nobili, F.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2016-03-01
- Volume
- 43
- Issue
- 7
- Pages
- 1337-1347
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2291146099
- Cited by
- 40
- References
- 9
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.